IBA overview

Announcement of the appointment of Catherine Vandenborre as CFO Louvain-la-Neuve, Belgium, 07 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, hosted its Capital Markets Day (CMD) today at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast. During the event, Olivier Legrain (CEO), Henri de Romrée (Deputy CEO), and the IBA management team outlined the company's purpose, vision, and strategy to shareholders,...

Louvain-La-Neuve, Belgium, April 2 nd , 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus ® ONE 1 compact proton therapy solution to be located at the Tri-Service General Hospital in Taipei, Taiwan. The contract includes the supply of a Proteus ® ONE system and a Quality Assurance...

Immediate Release – March 31 st , 2025 Louvain-la-Neuve, Belgium, March 31 st , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24 th , 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a...

Louvain-la-Neuve, Belgium, March 24 th , 2025 - Ion Beam Applications SA (IBA) announces today the launch of a share buyback program, effective as of March 25 th , 2025, in application of article 7:215 of the Belgian Companies and Associations Code. By a decision of the Board of Directors of March 18 th , 2025, taken pursuant to the authorization given by the EGM of September 4 th , 2023, IBA launched a program to buy back own shares through a mandate given to a market intermediary. This program...

Louvain-la-Neuve, Belgium, February 25, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation, and Jabil Inc. a global leader in engineering, manufacturing, and supply chain solutions, announced today they have signed a contract for the installation of a Be-Wide X-ray solution in a greenfield site in Byhalia, Mississippi, USA, to expand Jabil’s sterilization capabilities. The Be...

IBA SA – Section 15 of the transparency act February 11 th 6:00, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007) (hereinafter, the “Law”) Under this provision: "[...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as,...

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today announced they have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale...